TAC Cancer Research Results
TAC, total antioxidant capacity: Click to Expand ⟱
| Source: |
| Type: |
Total antioxidant capacity (TAC) refers to the ability of a biological sample (such as blood, tissues, or food) to counteract oxidative stress by neutralizing free radicals and reactive oxygen species (ROS).
May have reduced levels in cancers.
|
Scientific Papers found: Click to Expand⟱
*ROS↓, *TAC↑, *eff↑, *SOD↑, *GPx↑, *Catalase↑, *GlucoseCon↑, *antiOx↑,
*hepatoP↑, *PKM2↓, *Hif1a↓, *MDA↓, *Catalase↓, *GSH↑, *SOD↑, *GPx↑, *TAC↑, *α-SMA↓, *Vim↓, *ROS↓,
*memory↑, *AChE↓, *Aβ↓, *TNF-α↓, *IL1β↓, *lipid-P↓, *TAC↑, *BDNF↑, *β-catenin/ZEB1↑, *Dose↑,
*Imm↑, *Inflam↓, *Bacteria↓, *eff↑, *ROS↓, *MDA↓, *Catalase↑, *GSH↑, *TAC↑, *NF-kB↓, *NLRP3↓, *eff↑, *AST↓, *ALAT↓, *SOD↑, *GSTA1↑,
*NRF2↑, *NOX↓, *TAC↑, *ROS↓, *NQO1↑, *p‑PTEN↑, RUNX2↓, SOX9↓,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*Inflam↓, *antiOx↑, *AChE↓, *BBB↑, *cardioP↑, *neuroP↑, *memory↑, *TAC↑, *ROS↓, *lipid-P↓, *MDA↓, *SOD↑, *Catalase↑, *NRF2↑, *cognitive↑, *IL1β↓, *COX2↓, *TNF-α↓, *TLR4↓, *BDNF↑, *PKCδ↑, *5LO↓, *TRPM7↓, *GSH↑, *other↑, *Ferroptosis↓, *GPx4↑,
AntiCan↑, *chemoP↑, TNF-α↓, COX2↓, IL6↓, eff↑, PD-L1↓, *cognitive↓, *Aβ↓, *TAC↑, *SOD↑, *eff↑, *eff↑, ChemoSen↑, tumCV↓, Apoptosis↑, ERK↓, chemoP↑, *GPx↑, *GSTs↑, *GSH↑, *SOD↑, *Catalase↑, *ROS↓, *lipid-P↓, *MDA↓, *Casp3↓, *HO-1↓, cardioP↑, radioP↑,
NF-kB↓, Imm↑, *TAC↑, *MDA↓, ROS↑, TumAuto↑, TumCCA↑, Keap1↑, ChemoSen↑, ER Stress↑, eff↓, TrxR↓, STAT3↓, *BioAv↓,
*antiOx↑, radioP↑, RadioS∅, *TAC↑, *SOD↓,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Arthritis, |
NA |
|
|
|
*AntiCan↑, *AntiDiabetic↑, *cardioP↑, *toxicity↝, *GutMicro↑, *neuroP↑, *BioAv⇅, *BioAv↝, *antiOx↑, *Inflam↑, *AntiArt↑, *TNF-α↓, *IL6↓, *IL10↓, *GSH↑, *GPx↑, *Catalase↑, *MDA↓, *TAC↑, TumCMig↓, TumCI↓, Akt↑, FOXO3↑, Casp3↑, Casp9↑, P21↑, angioG↓, TumCI↓, Apoptosis↑, NF-kB↓, eff↑, eff↑, ChemoSen↑, NA↑, Casp3↑, Casp9↑, *AntiDiabetic↑, *glucose↓, *ROS↓, *Inflam↓, *MDA↓, *GSH↑, *BioAv↑,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*antiOx↑, *ROS↓, *BioAv↝, *Half-Life↑, *BioAv↓, *BioAv↑, *cardioP↑, *neuroP↑, *H2O2↓, *VitC↑, *VitE↑, *GPx↑, *GSH↑, *MPO↓, *GSTs↓, *SOD↑, *NF-kB↓, *IL1β↓, *IL6↓, *IL10↑, *MAPK↓, *Akt↓, *COX2↓, *TNF-α↓, *TGF-β1↑, *NO↓, *GSR↑, *NRF2↑, *HO-1↑, *TAC↑, *Inflam↓, *BBB↑, *neuroP↑, *memory↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*antiOx↑, *ROS↓, *SOD↑, *Catalase↑, *GSH↑, *GSTs↑, *MDA↓, *lipid-P↓, *NRF2↑, *HO-1↑, *iNOS↓, *NO↓, *TAC↑, *NOX4↓, *Inflam↓, *IL1↓, *IL6↓, *IL8↓, *IL1β↓, *TNF-α↓, *TLR2↓, *TLR4↓, *VCAM-1↓, *ICAM-1↓, *STAT3↓, *NF-kB↓, *ERK↓, *BP↓, ROS↓, PGE2↓, cardioP↑, *neuroP↑, *creat↓, *RenoP↑, *CRM↑,
*AntiDiabetic↑, *AntiAge↑, *toxicity⇅, *CRM↑, *Strength↑, *LDL↓, *AMPK↑, *TAC↑, *ROS↓, *Inflam↓, Risk↓, *cardioP↑, *ALAT↓, *NRF2↑, *SOD2↑, *TrxR1↑, *NQO1↑, *NQO2↑,
*SOD↑, *Catalase↑, *ROMO1↑, *MDA↓, *TAC↑, *ROS↓,
| - |
in-vivo, |
AD, |
NA |
|
|
|
- |
in-vivo, |
MS, |
NA |
|
|
|
*memory↑, *iNOS↓, *NRF2↑, *HO-1↑, *TAC↑, *TNF-α↓, *IL1β↓, *NF-kB↓, *IL10↑, *FOXP3↑, *BDNF↑, other↑,
ROS↑, cl‑Casp3↑, cl‑PARP↑, miR-21↓, PDCD4↑, TAC↑, tumCV↓, TumCI↓,
*Sepsis↓, *ROS↓, *SOD↑, *Catalase↑, *HMGB1↓, *Inflam↓, *TAC↑,
*Dose↝, *cognitive↑, *Aβ↓, *ROS↓, *TAC↑, *GutMicro↑, *BBB↑,
Casp3↑, PARP↑, survivin↓, miR-27a-3p↓, Sp1/3/4↓, ZBTB10↑, ROS⇅, TAC↑, tumCV↓,
*antiOx↑, *Thiols↑, *GSH↑, *TAC↑, *SOD↑, *GPx↑, *Catalase↑, *ALP↓, *ALAT↓, *AST↓, *creat↓, *BUN↓, *H2O2↓, *MDA↓, *ROS↓, cardioP↑, hepatoP↑, neuroP↑,
*TAC↑, *CRP↓, *AST↓, *ALAT↓, *toxicity↓, *GSH↑, *SOD↑, *Catalase↑, *hepatoP↑,
*NO↓, *MDA↓, *TAC↑, *Hif1a↓, *iNOS↓,
*ROS↓, *TAC↑, *NF-kB↓, *IL2↓, *NRF2↑, *HO-1↑, *neuroP↑, *Inflam↓, *NLRP3↓,
*RenoP↑, *ROS↓, *SIRT1↓, *NRF2↑, *HO-1↑, *GSH↑, *TAC↑, *SOD↑, *MDA↓, *NO↓, *iNOS↓, *NHE3↑, *PI3K↑,
*antiOx↑, *TOS↑, *TAC↑, *neuroP↑,
*RenoP↑, *TAC↑, *ROS↓, *lipid-P↓, *p38↓, *MAPK↓, *NF-kB↓, *NRF2↑, *HO-1↑, *MDA↓, *GPx↑, *GSR↑, *Catalase↑, *BUN↓, *LDH↓, *IL1β↓,
*cognitive↑, *SOD↑, *TAC↑, *AChE↓, *MDA↓, *NO↓, *TNF-α↓, *Bcl-2↑, *Ach↑, *neuroP↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*BioAv↓, *BioAv↑, *Inflam↓, *antiOx↑, *ROS↓, *GSH↑, *GSTs↑, *MPO↓, *NF-kB↓, *COX2↓, *IL1β↓, *TNF-α↓, *IFN-γ↓, *IL6↓, *cardioP↑, *lipid-P↓, *TAC↑, *RenoP↑, Apoptosis↑, TumCCA↑, TumCP↓, TumCMig↓, angioG↓, TNF-α↓, NF-kB↓, ROS↑, EMT↓, *Aβ↓, *p‑tau↓, *BACE↓, *TLR2↓, *TLR4↓, *MyD88↓, *IRF3↓, *eff↑, eff↑, DNAdam↑, *iNOS↓,
*Inflam↓, *antiOx↑, *Bacteria↓, AntiTum↑, *toxicity∅, *IBI↑, *ZO-1↑, *OCLN↑, *COX1↑, *TLR4↓, *NF-kB↓, *TNF-α↓, *IL1β↓, *TAC↑, *NRF2↑, *GutMicro↑,
Showing Research Papers: 1 to 29 of 29
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 29
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned ⓘ
NA↑, 1,
Redox & Oxidative Stress ⓘ
Keap1↑, 1, ROS↓, 1, ROS↑, 3, ROS⇅, 1, TAC↑, 2, TrxR↓, 1,
Cell Death ⓘ
Akt↑, 1, Apoptosis↑, 3, Casp3↑, 3, cl‑Casp3↑, 1, Casp9↑, 2, PDCD4↑, 1, survivin↓, 1,
Kinase & Signal Transduction ⓘ
SOX9↓, 1, Sp1/3/4↓, 1,
Transcription & Epigenetics ⓘ
miR-21↓, 1, miR-27a-3p↓, 1, other↑, 1, tumCV↓, 3,
Protein Folding & ER Stress ⓘ
ER Stress↑, 1,
Autophagy & Lysosomes ⓘ
TumAuto↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1, PARP↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence ⓘ
P21↑, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1, ERK↓, 1, FOXO3↑, 1, RUNX2↓, 1, STAT3↓, 1,
Migration ⓘ
TumCI↓, 3, TumCMig↓, 2, TumCP↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 2, ZBTB10↑, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, IL6↓, 1, Imm↑, 1, NF-kB↓, 3, PD-L1↓, 1, PGE2↓, 1, TNF-α↓, 2,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 3, eff↓, 1, eff↑, 4, RadioS∅, 1,
Clinical Biomarkers ⓘ
IL6↓, 1, PD-L1↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, AntiTum↑, 1, cardioP↑, 3, chemoP↑, 1, hepatoP↑, 1, neuroP↑, 1, radioP↑, 2, Risk↓, 1,
Total Targets: 58
Pathway results for Effect on Normal Cells:
NA, unassigned ⓘ
AntiArt↑, 1,
Redox & Oxidative Stress ⓘ
antiOx↑, 10, Catalase↓, 1, Catalase↑, 11, Ferroptosis↓, 1, GPx↑, 7, GPx4↑, 1, GSH↑, 12, GSR↑, 2, GSTA1↑, 1, GSTs↓, 1, GSTs↑, 3, H2O2↓, 2, HO-1↓, 1, HO-1↑, 6, lipid-P↓, 6, MDA↓, 14, MPO↓, 2, NOX4↓, 1, NQO1↑, 2, NRF2↑, 10, ROMO1↑, 1, ROS↓, 18, SOD↓, 1, SOD↑, 14, SOD2↑, 1, TAC↑, 27, Thiols↑, 1, TOS↑, 1, TrxR1↑, 1, VitC↑, 1, VitE↑, 1,
Core Metabolism/Glycolysis ⓘ
ALAT↓, 4, AMPK↑, 1, BUN↓, 2, CRM↑, 2, glucose↓, 1, GlucoseCon↑, 1, LDH↓, 1, LDL↓, 1, PKM2↓, 1, SIRT1↓, 1,
Cell Death ⓘ
Akt↓, 1, Bcl-2↑, 1, Casp3↓, 1, Ferroptosis↓, 1, iNOS↓, 5, MAPK↓, 2, p38↓, 1,
Transcription & Epigenetics ⓘ
Ach↑, 1, other↑, 1,
Protein Folding & ER Stress ⓘ
NQO2↑, 1,
Proliferation, Differentiation & Cell State ⓘ
ERK↓, 1, PI3K↑, 1, p‑PTEN↑, 1, STAT3↓, 1, TRPM7↓, 1,
Migration ⓘ
5LO↓, 1, PKCδ↑, 1, TGF-β1↑, 1, VCAM-1↓, 1, Vim↓, 1, ZO-1↑, 1, α-SMA↓, 1, β-catenin/ZEB1↑, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 2, NO↓, 5,
Barriers & Transport ⓘ
BBB↑, 3, IBI↑, 1, NHE3↑, 1, OCLN↑, 1,
Immune & Inflammatory Signaling ⓘ
COX1↑, 1, COX2↓, 3, CRP↓, 1, FOXP3↑, 1, HMGB1↓, 1, ICAM-1↓, 1, IFN-γ↓, 1, IL1↓, 1, IL10↓, 1, IL10↑, 2, IL1β↓, 8, IL2↓, 1, IL6↓, 4, IL8↓, 1, Imm↑, 1, Inflam↓, 10, Inflam↑, 1, MyD88↓, 1, NF-kB↓, 8, TLR2↓, 2, TLR4↓, 4, TNF-α↓, 9,
Cellular Microenvironment ⓘ
NOX↓, 1,
Synaptic & Neurotransmission ⓘ
AChE↓, 3, BDNF↑, 3, p‑tau↓, 1,
Protein Aggregation ⓘ
Aβ↓, 4, BACE↓, 1, NLRP3↓, 2,
Drug Metabolism & Resistance ⓘ
BioAv↓, 3, BioAv↑, 3, BioAv⇅, 1, BioAv↝, 2, Dose↑, 1, Dose↝, 1, eff↑, 6, Half-Life↑, 1,
Clinical Biomarkers ⓘ
ALAT↓, 4, ALP↓, 1, AST↓, 3, BP↓, 1, creat↓, 2, CRP↓, 1, GutMicro↑, 3, IL6↓, 4, LDH↓, 1,
Functional Outcomes ⓘ
AntiAge↑, 1, AntiCan↑, 1, AntiDiabetic↑, 3, cardioP↑, 5, chemoP↑, 1, cognitive↓, 1, cognitive↑, 3, hepatoP↑, 2, memory↑, 4, neuroP↑, 8, RenoP↑, 4, Strength↑, 1, toxicity↓, 1, toxicity⇅, 1, toxicity↝, 1, toxicity∅, 1,
Infection & Microbiome ⓘ
Bacteria↓, 2, IRF3↓, 1, Sepsis↓, 1,
Total Targets: 136
Scientific Paper Hit Count for: TAC, total antioxidant capacity
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:626 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page